188 related articles for article (PubMed ID: 24740103)
21. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies.
Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
[TBL] [Abstract][Full Text] [Related]
23. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
[TBL] [Abstract][Full Text] [Related]
24. EGF gene polymorphism and the risk of incident primary melanoma.
Amend KL; Elder JT; Tomsho LP; Bonner JD; Johnson TM; Schwartz J; Berwick M; Gruber SB
Cancer Res; 2004 Apr; 64(8):2668-72. PubMed ID: 15087376
[TBL] [Abstract][Full Text] [Related]
25. Pleckstrin homology-like domain family B member 1 rs498872 polymorphism and glioma risk in Chinese Han population.
Zhang JW; Liu ZH; Lin XH; Du YP; Guo HT
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):7-9. PubMed ID: 28886307
[TBL] [Abstract][Full Text] [Related]
26. Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma.
Zhang JN; Yi SH; Zhang XH; Liu XY; Mao Q; Li SQ; Xiong WH; Qiu YM; Chen T; Ge JW
Genet Mol Res; 2012 Oct; 11(4):3618-28. PubMed ID: 23096687
[TBL] [Abstract][Full Text] [Related]
27. Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis.
Wang Q; Xu L; Wu Q; Zhang M; Zhang J
Medicine (Baltimore); 2022 Oct; 101(42):e31280. PubMed ID: 36281156
[TBL] [Abstract][Full Text] [Related]
28. Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.
Meng LQ
Tumour Biol; 2014 Dec; 35(12):12497-508. PubMed ID: 25217982
[TBL] [Abstract][Full Text] [Related]
29. Association between EGF promoter polymorphisms and cancer risk: a meta-analysis.
Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
Med Oncol; 2010 Dec; 27(4):1389-97. PubMed ID: 20033794
[TBL] [Abstract][Full Text] [Related]
30. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
Wu D; Wu Y; Zhang X; Cong P; Lv X
Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
[TBL] [Abstract][Full Text] [Related]
31. Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis.
Lu Q; Dai D; Zhao W; Wang L; Yue Z; Chen X; Han G; Hao B; Yang P; Deng A; Liu J
Tumour Biol; 2013 Oct; 34(5):2801-7. PubMed ID: 23765760
[TBL] [Abstract][Full Text] [Related]
32. The genetic association between EGF A61G polymorphism (rs4444903) and risk of colorectal cancer: An update meta-analysis and trial sequential analysis.
Zhu Y; Chen Z; Jiang H; Lu B
Medicine (Baltimore); 2019 Jan; 98(2):e14007. PubMed ID: 30633190
[TBL] [Abstract][Full Text] [Related]
33. Association between the Thr241Met polymorphism of X-ray repair cross-complementing group 3 gene and glioma risk: evidence from a meta-analysis based on 4,136 cases and 5,233 controls.
Lin J; Kou Y
Tumour Biol; 2014 Jan; 35(1):425-32. PubMed ID: 23918307
[TBL] [Abstract][Full Text] [Related]
34. Association between functional polymorphism in EGF gene and malignant melanoma.
Shahbazi M; Pravica V; Nasreen N; Fakhoury H; Fryer AA; Strange RC; Hutchinson PE; Osborne JE; Lear JT; Smith AG; Hutchinson IV
Lancet; 2002 Feb; 359(9304):397-401. PubMed ID: 11844511
[TBL] [Abstract][Full Text] [Related]
35. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
36. Association between glutathione S-transferase T1 null genotype and glioma susceptibility: a meta-analysis.
Zhang B; Wang J; Niu H; Li Y; Yuan F; Tian Y; Zhou F; Hao Z; Zheng Y; Li Q; Wang W
Tumour Biol; 2014 Mar; 35(3):2081-6. PubMed ID: 24122206
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls.
Li TF; Ren KW; Liu PF
DNA Cell Biol; 2012 Apr; 31(4):568-74. PubMed ID: 22070650
[TBL] [Abstract][Full Text] [Related]
38. Association Between
Guo H; Liao Y; Lin A; Lin H; Huang X; Ruan J; Yuan L; Zhuo Z
Cancer Control; 2021; 28():10732748211040009. PubMed ID: 34468231
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility.
Zhu W; Yao J; Li Y; Xu B
Tumour Biol; 2014 Apr; 35(4):3061-6. PubMed ID: 24258108
[TBL] [Abstract][Full Text] [Related]
40. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
Wu Q; Peng Y; Zhao X
Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
